Jean-louis L. Abitbol
Daix, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Altered liver sinusoidal endothelial cells in MASLD and their evolution following lanifibranor treatment.
Journal: JHEP reports : innovation in hepatology
Published: September 27, 2024
Biomarkers of Histological Response in Lanifibranor-treated Patients With Metabolic Dysfunction-associated Steatohepatitis.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: August 03, 2024
Biomarkers of Glycosaminoglycans (GAG) accumulation in patients with mucopolysaccharidosis type VI-LeukoGAG, Corneal Opacification (COM) and Carotid Intima Media Thickening (CIMT).
Journal: Molecular genetics and metabolism reports
Published: December 12, 2023
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH.
Journal: The New England journal of medicine
Published: October 20, 2021
Oral treatment for mucopolysaccharidosis VI: Outcomes of the first phase IIa study with odiparcil.
Journal: Journal of inherited metabolic disease
Published: July 19, 2021
Resetting the Abnormal Circadian Cortisol Rhythm in Adrenal Incidentaloma Patients With Mild Autonomous Cortisol Secretion.
Journal: The Journal of clinical endocrinology and metabolism
Published: April 06, 2017
Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: a randomised, double-blind, placebo-controlled phase 2 trial.
Journal: The Lancet. Neurology
Published: October 12, 2016
A prospective, randomized, pharmacodynamic study of quick-starting a desogestrel progestin-only pill following ulipristal acetate for emergency contraception.
Journal: Human reproduction (Oxford, England)
Published: May 29, 2015
Translation of TRO40303 from myocardial infarction models to demonstration of safety and tolerance in a randomized Phase I trial.
Journal: Journal of translational medicine
Published: October 09, 2013
A phase II-III trial of olesoxime in subjects with amyotrophic lateral sclerosis.
Journal: European journal of neurology
Published: August 05, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026